About Jakob Loven
Form D filings for IconOVir Bio from 2020 to 2024 list Jakob Loven as director.
Jakob Loven reports to the SEC as a director of 2 public companies: Kronos Bio (KRON) and Arvinas (ARVN).
Jakob Loven first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Jakob Loven in the role, so the role may have started earlier or lasted longer.
KI
Kronos Bio, Inc.
Director
2020 – 2021 · Public company (KRON)
AI
Arvinas, Inc.
Director
2018 – 2020 · Public company (ARVN)
Key Colleagues at Startups
The people Jakob Loven works with at each company, as listed on that company's latest Form D.
IconOVir Bio, Inc. · Form D/A, Jun 4, 2024
SA
Sean Algeo
Executive officer and promoter
NL
Nicole van de Leuv
Executive officer
HK
Helen Kim
Director
HN
Heba Nowyhed
Executive officer
DC
David Chang
Director and promoter
WK
William Kaelin
Director
JK
Joshua Kazam
Director and promoter
JM
Julie Maltzman
Executive officer
MM
Mark McCamish
Executive officer and director
JH
John Huynh
Executive officer
DT
David Tanen
Secretary